Figure 8

Histopathological changes in the liver of normal and STZ-NA-induced diabetic rats. (A) Normal Control. (B) Diabetic control. (C) STZ-NA-induced diabetic rats treated with compound 1a (36 mg/kg body weight); (D) STZ-NA-induced diabetic rats treated with compound 1i (36 mg/kg body weight); (E) STZ-NA-induced diabetic rats treated with compound 3a (36 mg/kg body weight); (F) STZ-induced diabetic rats treated with Pioglitazone (36 mg/kg body weight). Examinations were carried out at 40x magnifications with hematoxylin-eosin’s stain.